Patents by Inventor Jack W. Szostak

Jack W. Szostak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8207093
    Abstract: Described herein are RNA-protein fusion production methods which involve a high salt post-translational incubation step.
    Type: Grant
    Filed: July 6, 2007
    Date of Patent: June 26, 2012
    Assignee: The General Hospital Corporation
    Inventors: Jack W. Szostak, Richard W. Roberts, Rihe Liu
  • Publication number: 20110105995
    Abstract: Uniform-sized liposome populations can improve both the efficacy and safety of drug delivery. The present invention utilizes the techniques of extrusion with polycarbonate-membrane-based large-pore dialysis to create uniform-sized liposome populations. These uniform-sized liposome populations may comprise different sizes such that smaller liposome populations contain specific drugs that are compartmentalized within a larger liposome population. These uniform-sized liposomes can be lysed upon photoillumination and release the encapsulated drugs and/or smaller liposomes, and can be used as a new version of photodynamic therapy.
    Type: Application
    Filed: January 13, 2009
    Publication date: May 5, 2011
    Inventors: Ting F. Zhu, Jack W. Szostak
  • Patent number: 7270950
    Abstract: Described herein are RNA-protein fusion production methods which involve a high salt post-translational incubation step.
    Type: Grant
    Filed: June 6, 2001
    Date of Patent: September 18, 2007
    Assignee: The General Hospital Corporation
    Inventors: Jack W. Szostak, Richard W. Roberts
  • Patent number: 7138253
    Abstract: The invention provides peptides with high affinity for streptavidin. These peptides may be expressed as part of fusion proteins to facilitate the detection, quantitation, and purification of proteins of interest.
    Type: Grant
    Filed: October 28, 2004
    Date of Patent: November 21, 2006
    Assignee: The General Hospital Corporation
    Inventors: Jack W. Szostak, David S. Wilson, Anthony D. Keefe
  • Patent number: 6841359
    Abstract: The invention provides peptides with high affinity for streptavidin. These peptides may be expressed as part of fusion proteins to facilitate the detection, quantitation, and purification of proteins of interest.
    Type: Grant
    Filed: October 31, 2001
    Date of Patent: January 11, 2005
    Assignee: The General Hospital Corporation
    Inventors: Jack W. Szostak, David S. Wilson, Anthony D. Keefe
  • Publication number: 20040253612
    Abstract: Described herein are RNA-protein fusion production methods which involve a high salt post-translational incubation step.
    Type: Application
    Filed: January 26, 2004
    Publication date: December 16, 2004
    Inventors: Jack W. Szostak, Richard W. Roberts
  • Patent number: 6518018
    Abstract: Described herein are methods and reagents for the selection of protein molecules that make use of RNA-protein fusions.
    Type: Grant
    Filed: January 28, 1999
    Date of Patent: February 11, 2003
    Assignee: The General Hospital Corporation
    Inventors: Jack W. Szostak, Richard W. Roberts
  • Publication number: 20030022236
    Abstract: Described herein are RNA-protein fusion production methods which involve a high salt post-translational incubation step.
    Type: Application
    Filed: June 6, 2001
    Publication date: January 30, 2003
    Inventors: Jack W. Szostak, Richard W. Roberts, Rihe Liu
  • Publication number: 20020155578
    Abstract: The invention provides peptides with high affinity for streptavidin. These peptides may be expressed as part of fusion proteins to facilitate the detection, quantitation, and purification of proteins of interest.
    Type: Application
    Filed: October 31, 2001
    Publication date: October 24, 2002
    Inventors: Jack W. Szostak, David S. Wilson, Anthony D. Keefe
  • Patent number: 6281344
    Abstract: Described herein are methods and reagents for the selection of protein molecules that make use of RNA-protein fusions.
    Type: Grant
    Filed: February 5, 1999
    Date of Patent: August 28, 2001
    Assignee: The General Hospital Corporation
    Inventors: Jack W. Szostak, Richard W. Roberts, Rihe Liu
  • Patent number: 6261804
    Abstract: Described herein are RNA-protein fusion production methods which involve a high salt post-translational incubation step.
    Type: Grant
    Filed: February 9, 1999
    Date of Patent: July 17, 2001
    Assignee: The General Hospital Corporation
    Inventors: Jack W. Szostak, Richard W. Roberts, Rihe Liu
  • Patent number: 6258558
    Abstract: Described herein are methods and reagents for the selection of protein molecules that make use of RNA-protein fusions.
    Type: Grant
    Filed: January 14, 1998
    Date of Patent: July 10, 2001
    Assignee: The General Hospital Corporation
    Inventors: Jack W. Szostak, Richard W. Roberts, Rihe Liu
  • Patent number: 6238865
    Abstract: A novel 3′-terminus modified nucleic acid and a method of making such product using a synthetic nucleotide template with a defined overhang nucleotide are disclosed. The method allows an efficient incorporation of a single modified nucleotide onto the 3′-terminus of the nucleic acid.
    Type: Grant
    Filed: October 16, 1998
    Date of Patent: May 29, 2001
    Inventors: Zhen Huang, Jack W. Szostak
  • Patent number: 6214553
    Abstract: Described herein are methods and reagents for the selection of protein molecules that make use of RNA-protein fusions.
    Type: Grant
    Filed: February 5, 1999
    Date of Patent: April 10, 2001
    Assignee: Massachusetts General Hospital
    Inventors: Jack W. Szostak, Richard W. Roberts, Rihe Liu
  • Patent number: 6207446
    Abstract: Described herein are methods and reagents for the selection of protein molecules that make use of RNA-protein fusions.
    Type: Grant
    Filed: October 29, 1999
    Date of Patent: March 27, 2001
    Assignee: The General Hospital Corporation
    Inventors: Jack W. Szostak, Richard W. Roberts, Rihe Liu
  • Patent number: 5910408
    Abstract: The invention features nucleic acid molecules and, in particular, DNA molecules having catalytic activity, as well as methods for obtaining and using such nucleic acid molecules.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: June 8, 1999
    Assignee: The General Hospital Corporation
    Inventors: Jack W. Szostak, Bernard Cuenoud, David E. Huizenga
  • Patent number: 5688670
    Abstract: The invention concerns a method for creating, identifying, and isolating ribozymes capable of binding a selected ligand and catalyzing a reaction involving the selected ligand. The method entails sequential selections for ligand binding molecules and catalytic molecules. The invention also includes novel ribozymes produced by these methods.
    Type: Grant
    Filed: September 1, 1994
    Date of Patent: November 18, 1997
    Assignee: The General Hospital Corporation
    Inventors: Jack W. Szostak, Jon R. Lorsch, Charles Wilson
  • Patent number: 5652107
    Abstract: There are provided nucleic acid hybridization assays for RNA targets using RNA binary probes and a ribozyme ligase that is a stringent RNA-directed RNA ligase. Preferred assays include exponential amplification for signal generation. Tetrahymena ribozyme ligase is a preferred ligase for use in this invention. It may be tethered to hold it close to the ligation junction. One assay according to this invention is a "tethered ligase chain reaction." Also provided are kits for performing assays according to the invention.
    Type: Grant
    Filed: July 15, 1996
    Date of Patent: July 29, 1997
    Assignee: The Public Health Research Institute of the City of New York, Inc.
    Inventors: Paul M. Lizardi, Sanjay Tyagi, Ulf D. Landegren, Fred R. Kramer, Jack W. Szostak
  • Patent number: 5631146
    Abstract: Disclosed are single-stranded DNA molecules which bind adenosine or an adenosine-5'-phosphate and methods for their production and isolation. Also disclosed are methods for producing and isolating related catalytic DNA molecules.
    Type: Grant
    Filed: January 19, 1995
    Date of Patent: May 20, 1997
    Assignee: The General Hospital Corporation
    Inventors: Jack W. Szostak, David E. Huizenga
  • Patent number: 5268285
    Abstract: The present invention provides a process for increasing the rate of production of carbon dioxide, ethanol and other fermentation products such as citric acid, produced by yeast such as Saccharomyces cerevisiae during fermentation, and decreasing biomass production by regulating the rate of glycolysis indirectly through changing the energy balance of the cell, i.e., by reducing intracellular ATP levels. Modifications for so altering the glycolysis rate involve the use of either a regulated ATP hydrolysis within the cell or a regulated leakage of ATP from the cell.
    Type: Grant
    Filed: July 22, 1991
    Date of Patent: December 7, 1993
    Assignee: Genetics Institute, Inc.
    Inventors: David T. Rogers, Jack W. Szostak